Navigation Links
Telik Announces Year-End Financial Release, Conference Call and Webcast
Date:2/14/2008

PALO ALTO, Calif., Feb. 14 /PRNewswire-FirstCall/ -- Telik, Inc. (Nasdaq: TELK) announced that its year-end conference call and webcast will be held on Thursday, February 21, 2008 at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) following the release earlier that day of the company's financial results for the fourth quarter and year ended December 31, 2007.

The conference call will be accessible via Telik's website at http://www.telik.com or by telephone at 800-398-9398 or 612-332-0530. An archive of the conference call will be available on the Telik website or by telephone at 800-475-6701 or 320-365-3844, access code 910785. The archive will be available from approximately 6:30 p.m. Eastern time on February 21 through March 6, 2008.

Telik, Inc. of Palo Alto, CA is a biopharmaceutical company focused on discovering, developing and commercializing novel small molecule drugs to treat serious diseases. The company's most advanced drug development candidates are TELCYTA(R), a tumor-activated small molecule product candidate in clinical development for the treatment of advanced ovarian cancer and non- small cell lung cancer; and TELINTRA(R), which is in clinical development for the treatment of myelodysplastic syndrome. Telik's product candidates were discovered using its proprietary drug discovery technology, TRAP(TM), which enables the rapid and efficient discovery of small molecule drug candidates.


'/>"/>
SOURCE Telik, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Telik Announces Presentation and Webcast at Bear Stearns Healthcare Conference
2. Telik Announces Presentation and Webcast at UBS Global Life Sciences Conference
3. Telik Announces Presentation and Webcast at JPMorgan Healthcare Conference
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
6. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
7. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
8. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
9. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
10. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
11. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... recently approved the Promega PowerPlex 16 HS Sys...nerating DNA records for the National DNA Index Sy...PRWEB) -- The FBI recently approved the Promega P...s participating in, or generating DNA records for,...tly contains more than seven million profiles and ...
(Date:11/24/2009)... 24 Shire plc (LSE: SHP,...eutical company, today,announced that it has submi...laglucerase alfa, the company,s enzyme replacement...1 Gaucher disease. This is the third marketing,app...itted, with previous,submissions in the United Sta...
(Date:11/24/2009)...November 24 Health Robotics today ...venture with a group of selected,investors. This r...under the,name Health Robotics Canada, Inc. and wi....v. Room of the Future concept, which includes the...i.v.SOFT(TM), and OMM(TM).,Health Robotics Canada ...
(Date:11/24/2009)... Cell Therapeutics, Inc. ...nt at the 21st Annual Piper Jaffray Health Care Co..., 2009, at the New York Palace Hotel. ,, CTI ...Eastern Time in Holmes 1 (4th Floor). A live audio...t www.celltherapeutics.com , and it will also be ...
Breaking Biology Technology:NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 3
..., May 19 MedClean Technologies, Inc. (OTC Bulleti...ed a private offer to exchange all of the Company,...tial Exercise Dates between July 11, 2008 and Augu... Common Stock Purchase Warrants, with a new lower ...ares of our common stock, par value $0.0001 per sh...
...., May 19 In an eleventh-hour attempt to smear T...Y ) has issued a press release claiming that there...r. Richard Rosenbloom, a key staff member of a sub...a group of dissident shareholders who have offered...or election at the annual meeting scheduled for We...
...hina, May 19 /PRNewswire-Asia-FirstCall/ -- China ...the Company") (Nasdaq: CSKI ), a leading,fully i...e-counter drugs in,the People,s Republic of China ...rhouse Coopers ("PWC") to assist the Company in co...equirements of Sarbanes-Oxley Act Section 404,("SO...
Other Biology Technology:MedClean Technologies, Inc. Announces Private Offer to Exchange Warrants 2MedClean Technologies, Inc. Announces Private Offer to Exchange Warrants 3MedClean Technologies, Inc. Announces Private Offer to Exchange Warrants 4In Eleventh-Hour Smear Attempt, Quigley Management Sacrifices Key Employee of its Pharma Division 2In Eleventh-Hour Smear Attempt, Quigley Management Sacrifices Key Employee of its Pharma Division 3China Sky One Medical, Inc. Appoints Pricewaterhouse Coopers to Help Develop a SOX 404 Compliance Program 2China Sky One Medical, Inc. Appoints Pricewaterhouse Coopers to Help Develop a SOX 404 Compliance Program 3
(Date:11/26/2009)..., Heidelberg, 27 November 2009 What are the ba...ts required to produce a cell that can survive on ...a cell, and understand how an entire organism func...tions that scientists in a partnership between the...eidelberg, Germany, and the Centre de Regulacio Ge...
(Date:11/25/2009)... On September 11, firefighters, police officers an...rt in the World Trade Center complex. They battled...earched for survivors, tackled fires and evacuated...tained an estimated 17,000 people. And making thei...cations: frightened workers and their relatives ja...
(Date:11/25/2009)..., LA JOLLA, CAWhen you eat may be just as vital t...t the Salk Institute for Biological Studies. Their...g and waning of thousands of genes in the liverthe...d by food intake and not by the body,s circadian c...ng time determines the activity of a large number ...
Breaking Biology News(10 mins):First-ever blueprint of a minimal cell is more complex than expected 2First-ever blueprint of a minimal cell is more complex than expected 3Magic box for mission impossible 2Magic box for mission impossible 3Feeding the clock 2Feeding the clock 3Oxygen Biotherapeutics Inc to Present at Investment Conferences in New York and Zurich 13695 1Oxygen Biotherapeutics Inc to Present at Investment Conferences in New York and Zurich 13695 2NIAID Awards New Grant to Expand Studies of Peregrines Anti PS Antibodies to Treat Viral Hemorrhagic Fevers 55384 1NIAID Awards New Grant to Expand Studies of Peregrines Anti PS Antibodies to Treat Viral Hemorrhagic Fevers 55384 2NIAID Awards New Grant to Expand Studies of Peregrines Anti PS Antibodies to Treat Viral Hemorrhagic Fevers 55384 3NIAID Awards New Grant to Expand Studies of Peregrines Anti PS Antibodies to Treat Viral Hemorrhagic Fevers 55384 4NIAID Awards New Grant to Expand Studies of Peregrines Anti PS Antibodies to Treat Viral Hemorrhagic Fevers 55384 5American Brain Tumor Association Statement on the Death of U S Senator Edward M Kennedy 55380 1
...reasing attention given to the potential of biocha... wood) to serve as a long term sink of carbon in t...nd breaks down extremely slowly, persisting in soi...estion being seriously considered by policy makers... quantities and stored in soils. This would in tur...
... in French . , Canadian, French and British re...rols the variability of blood glucose levels in pe...because high blood glucose levels in otherwise hea... and higher mortality rates. The results will be p...l Science. , The research was conducted by Dr. P...
...Texas The first year of ConocoPhillips [NYSE:COP]...a State University (ISU) has supported 26 research...orations to further diversify Americas sources of ...ocoPhillips, the third-largest integrated energy c...n to begin 14 research projects at ISU in 2007. Th...
Other Biology News:Limitations of charcoal as an effective carbon sink 2Genetic breakthrough explains dangerously high blood glucose levels 2Genetic breakthrough explains dangerously high blood glucose levels 3Iowa State-ConocoPhillips collaboration advances 26 research projects in first year 2
...CC1041 is a recombinant 177 amino acid polypeptide... human MT1-MMP. Produced by activation of a recom... coli periplasm. SPECIFIC ACTIVITY:The specific a..., where 1 U is the activity that hydrolyzes 1 mol ...
...The EC570-90 is a compact, lightweight, high curre...ts or 2500 milliamps. It is an excellent choice fo... is also ideal for all types of electroblotting ap...t to automatically end a run and wil automatically...
Anti-Interferon-beta (IFNb) Monoclonal Antibody, Unconjugated from CHEMICON
...For use in Refrigerated Vapor Trap Models RVT100, ...urce (UVS) Models UVS400, UVS400A and UVS800DDA.,...licone polymer suitable for use for temperatures r... has excellent thermal stability and does not evap...
Biology Products: